Alpha Tau Medical Ltd (DRTS)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $1.24B
Last updated: Nov 17, 2026 at 4:40 PM ET
Alpha Tau Medical Ltd (DRTS) Statistics
Alpha Tau Medical (DRTS) has a market cap of $1.24B and an enterprise value of $1.22B. Its share count is up 13.05% from a year earlier.
Total Valuation
Enterprise value is 1.20% below the market cap, as cash exceeds debt.
| Market Cap | $1.24B |
|---|---|
| Enterprise Value | $1.22B |
| Latest price (Nov 17, 2026) | $12.09 |
Key Dates
The next earnings report is expected on Nov 24, 2026, covering the quarter ending Sep 30, 2026.
| Next Earnings Date | Nov 24, 2026 (expected) |
|---|---|
| Last Earnings Date | Aug 10, 2026 |
| Fiscal Year End | December |
Price Statistics
The stock is up 225.53% over 52 weeks and trades 13.33% below its 50-day average.
| Beta (1Y) | 2.14 |
|---|---|
| 52-Week Change | +225.53% |
| 1-Month Change | -4.20% |
| 3-Month Change | -16.45% |
| 6-Month Change | +13.20% |
| 5-Year Change | +31.52% |
| Total Return (1Y) | +225.53% |
| Total Return (3Y CAGR) | +58.25% |
| Total Return (5Y CAGR) | +4.06% |
| Return vs SPY (1Y) | +216.97% |
| Max Drawdown (1Y) | -23.87% |
| Max Drawdown (3Y) | -41.67% |
| Sharpe Ratio (1Y) | 1.57 |
| Correlation with SPY (1Y) | 0.39 |
| 50-Day Average | $13.95 |
| 200-Day Average | $10.97 |
| 52-Week Range | $3.43 to $15.79 |
| RSI (14 Days) | 38.2 |
| Average Volume (20 Days) | 609.31K |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 11.09x current liabilities, and total debt is 0.18x shareholder equity.
| Current Ratio | 11.09x |
|---|---|
| Quick Ratio | 11.09x |
| Debt / Equity | 0.18x |
Returns and Efficiency
Return on invested capital is -176.93% over the last 12 months, against a 5-year average of -23.57%.
| Return on Equity (ROE) | -210.13% |
|---|---|
| Return on Assets (ROA) | -68.96% |
| Return on Invested Capital (ROIC) | -176.93% |
| Return on Capital Employed (ROCE) | -74.08% |
| ROIC (5Y Average) | -23.57% |
Scores
DRTS has a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 3 of 9 |
|---|---|
| Piotroski Strength | Average |
Income Statement
Revenue was $0 over the last 12 months.
| Revenue | $0 |
|---|---|
| Operating Income | -$50.43M |
| Pretax Income | -$92.40M |
| Net Income | -$92.57M |
| EBITDA | -$49.07M |
| EBIT | -$92.31M |
| Reported EPS (TTM) | -$1.04 |
Trailing 12 months through Jun 30, 2026.
Balance Sheet
Shareholder equity funds 32.81% of the $134.25M in total assets.
| Cash and Equivalents | $22.99M |
|---|---|
| Total Debt | $8.12M |
| Net Cash | $14.87M |
| Net Cash Per Share | $0.16 |
| Working Capital | $97.20M |
| Shareholder Equity | $44.05M |
| Book Value Per Share | $0.48 |
| Total Assets | $134.25M |
| Total Liabilities | $90.19M |
Balance sheet as of Jun 30, 2026.
Cash Flow
| Capital Expenditures | $6.08M |
|---|---|
| FCF Per Share | -$0.42 |
Trailing 12 months through Jun 30, 2026.
Growth
| Book Value Per Share Growth (2Y CAGR) | -13.85% |
|---|---|
| Tangible Book Per Share Growth (2Y CAGR) | -13.85% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About DRTS
What is DRTS's market cap?
Alpha Tau Medical has a market cap of $1.24B. Its enterprise value, which adds debt and subtracts cash, is $1.22B.
How many shares of DRTS are outstanding?
Alpha Tau Medical has 90.95M shares outstanding. The count is up 13.05% from a year earlier.
Does DRTS pay a dividend?
No. Alpha Tau Medical does not pay a dividend.
How much debt does DRTS have?
Alpha Tau Medical has $8.12M of total debt and $22.99M of cash and equivalents, a net cash position of $14.87M.
DRTS pages: Overview, Charting, Earnings, Forecast, Statistics, Competitors